Abivax Socit Anonyme Stock Cash Position Weight
| AAVXF Stock | USD 11.05 0.00 0.00% |
ABIVAX Socit Anonyme fundamentals help investors to digest information that contributes to ABIVAX Société's financial success or failures. It also enables traders to predict the movement of ABIVAX Pink Sheet. The fundamental analysis module provides a way to measure ABIVAX Société's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ABIVAX Société pink sheet.
ABIVAX |
ABIVAX Socit Anonyme Company Cash Position Weight Analysis
ABIVAX Société's Percentage of fund asset invested in cash equivalents or risk-free instruments. About 40% of all global funds carry cash on their balance sheet.
Funds or ETFs that have over 40% of their value invested in low-risk instruments or cash equivalents typically attract conservative investors.
| Competition |
In accordance with the recently published financial statements, ABIVAX Socit Anonyme has 0.0% in Cash Position Weight. This indicator is about the same for the Healthcare average (which is currently at 0.0) sector and about the same as Biotechnology (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Did you try this?
Run Top Crypto Exchanges Now
Top Crypto ExchangesSearch and analyze digital assets across top global cryptocurrency exchanges |
| All Next | Launch Module |
ABIVAX Fundamentals
| Return On Equity | -12.86 | |||
| Return On Asset | -0.44 | |||
| Operating Margin | 4.66 % | |||
| Current Valuation | 165.28 M | |||
| Shares Outstanding | 22.3 M | |||
| Shares Owned By Insiders | 4.67 % | |||
| Shares Owned By Institutions | 57.27 % | |||
| Price To Earning | (7.88) X | |||
| Price To Book | 27.57 X | |||
| Price To Sales | 20.65 X | |||
| Revenue | 37 K | |||
| Gross Profit | (45.52 M) | |||
| EBITDA | (42.25 M) | |||
| Net Income | (41.36 M) | |||
| Cash And Equivalents | 26.57 M | |||
| Cash Per Share | 1.58 X | |||
| Total Debt | 53.45 M | |||
| Debt To Equity | 8.03 % | |||
| Current Ratio | 2.03 X | |||
| Book Value Per Share | 0.36 X | |||
| Cash Flow From Operations | (45.66 M) | |||
| Earnings Per Share | (2.59) X | |||
| Number Of Employees | 24 | |||
| Beta | 1.26 | |||
| Market Capitalization | 165.36 M | |||
| Total Asset | 110.36 M | |||
| Z Score | 1.8 | |||
| Net Asset | 110.36 M |
About ABIVAX Société Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ABIVAX Socit Anonyme's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ABIVAX Société using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ABIVAX Socit Anonyme based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in ABIVAX Pink Sheet
ABIVAX Société financial ratios help investors to determine whether ABIVAX Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ABIVAX with respect to the benefits of owning ABIVAX Société security.